STAT

JANUARY 18, 2024

This was back in 2013, when such accommodations were a rarity. Even though Erin Booth was not thrilled about having to travel to Philadelphia for a conference at six weeks postpartum, this one at least advertised having a private lactation space.

145

145

STAT

JULY 19, 2024

The first time I saw Maya (not her real name) huddled under blankets in a hospital bed in 2013, she had been to dozens of inpatient detox programs and residential treatment centers since she had begun using heroin two decades earlier. After every release, she returned to heroin use, usually within days.

Hospitals 139

Hospitals 139

STAT

AUGUST 19, 2024

The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments.

Medical Schools 144

Medical Schools Pharmaceutical Companies Pharmaceutical Companies 144

Pharmacy Times

MARCH 11, 2024

The early phase clinical trial, which ended prematurely in 2013 due to funding challenges, further illustrates disparities in health equity in clinical research.

50

50

STAT

FEBRUARY 28, 2024

Bik first became interested in plagiarism as a hobby while working as a researcher at Stanford University in 2013. She later began specializing in image duplication specifically, which she believes is a more serious problem for science as a whole. Read the rest…

144

144

European Pharmaceutical Review

FEBRUARY 23, 2024

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Richard has facilitated AbbVie securing a market capitalisation increase from $54 billion in 2013 to over $300 billion in 2024.

Hospitals 97

Hospitals 97

Med Ed 101

OCTOBER 4, 2023

It’s hard to believe that I have been following pharmacist board certifications and helping pharmacists pass the BCPS exam for over 10 years since I first passed it in 2013! Each year in updating and creating our study materials, I review the content outline and any possible changes in the BCPS exam.

111

111

STAT

SEPTEMBER 20, 2024

In 2013, I sat down at my computer and secured the URL t1international.com. I wanted a place where I could collect and share everything I was learning about the global insulin price crisis. I was only 25 years old, and I had already been living with type 1 diabetes for more than two decades.

Hospitals 132

Hospitals 132

STAT

JANUARY 3, 2024

billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 Around $25.6 billion had been raised by 556 first-time funds in 2022.

145

145

STAT

MARCH 28, 2024

From 2013 to 2022, pharmaceutical and device companies made more than 85 million payments totaling $12.1 The financial ties between drug and device makers and some physicians remains pervasive, despite concerns such relationships may influence medical practice, according to a new analysis of payments made over a recent 10-year span.

142

142

STAT

NOVEMBER 18, 2023

It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. Jennifer Doudna and Emmanuelle Charpentier, now Nobelists , published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9.

145

145

Fierce Pharma

MARCH 13, 2024

The company in 2022 claimed the research university breached its contracts relating to a joint trial the two ran in 2013 and wrongly secured patents for itself from the study. Patent and Trademark Office (PTO) to weigh in following a 2022 complaint. | Now, Merck is taking its complaints to the patent office.

73

73

STAT

FEBRUARY 20, 2024

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July.

140

140

STAT

DECEMBER 8, 2023

Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics were all started in the 2013-2014 time frame with the same goal of turning the nascent CRISPR gene-editing technology into medicines.

134

134

STAT

OCTOBER 11, 2023

So far this year, there have been 1,384 VC deals struck in the field, the lowest figure since 2013. New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly.

137

137

Pharmaceutical Technology

MARCH 12, 2024

Butterworth Laboratories looks at the current amino acid testing landscape since the changes in monographs introduced in 2013.

52

52

STAT

FEBRUARY 12, 2024

Over the past decade, the number of research misconduct allegations reported to the National Institutes of Health has more than doubled, climbing from 74 in 2013 to 169 in 2022. And it’s hardly alone. And scientific sleuths are finding plenty of other problems that don’t always qualify as outright misconduct.

145

145

STAT

APRIL 7, 2024

In 2013, it took an average of 9.9 In some cases, failure to show clinical benefit didn’t stop the FDA from converting accelerated approvals into full approvals, and the authors note the agency’s conversion decisions have increasingly been based on less stringent evidence of a drug’s benefits.

FDA 142

FDA 142

STAT

MAY 7, 2024

The company, which last month pleaded guilty to a misdemeanor, admitted that, from April 2012 through May 2013, some of its sales representatives marketed its medicine, also known as oxymorphone, to doctors by touting the drug as abuse deterrent, as well as resistant to tampering and crushing.

Pharmaceutical Companies 117

Pharmaceutical Companies Pharmaceutical Companies 117

Blog: Ask a Student Pharmacist

OCTOBER 4, 2023

Minneceutics Newsletter eomizowh Wed, 10/04/2023 - 12:47 Current Newsletter Expand all + Archive 1993 1994 1995 1999 2000 2001 2002 2003 2004 2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

52

52

STAT

APRIL 23, 2024

Case in point: Under the seemingly benign title, “Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval,” an article published recently in the Journal of the American Medical Association claims that among “cancer drugs granted accelerated approval from 2013 to 2017, 41% (19/46) did not improve (..)

FDA 114

FDA 114

STAT

DECEMBER 20, 2022

For example, the share of Mexican Americans taking insulin who achieved good blood-sugar control sharply dropped to 10% during the period of 2013 to 2020 from 25% during 1988 to 1994, researchers reported Tuesday in JAMA Network Open. Read the rest…

100

100

STAT

NOVEMBER 10, 2022

He has been part of the C-suite at Sage Therapeutics since 2013. Longtime Sage Therapeutics executive Jeff Jonas is leaving the biotech company to launch a biotech incubator with global investment giant CBC Group. Sage announced this week that Jonas would leave the company to join a private equity firm. billion deal with Biogen.

108

108

STAT

SEPTEMBER 28, 2023

million from 2013 to 2019, presumably due to the company payments, according to the study, which was published in JAMA Health Forum. Physicians who did not accept payments prescribed Avastin 46% of the time, nearly twice as often as those who accepted payments. As a result, Medicare shelled out an estimated $642.8

Insurance 128

Insurance 128

Blog: Ask a Student Pharmacist

AUGUST 21, 2024

Halil Ibrahim Ergen pbhamidi Wed, 08/21/2024 - 08:24 Expand all + Research Interests Hand rehabilitation PhD, in Occupational Therapy, Hacettepe University-Türkiye (2021) Master of Science , in Occupational Therapy, Hacettepe University-Türkiye (2015) Bachelor of Science, in Physiotherapy and Rehabilitation, Gazi University-Türkiye (2013) Email hergen@umn.edu (..)

52

52

STAT

MAY 19, 2023

Founded in 2013, Pear was the most prominent company developing prescription digital therapeutics, or Food and Drug Administration-cleared software applications ordered by doctors to treat health conditions. Click Therapeutics, Welt Corp, Harvest Bio, and Nox Health Group each acquired bits of the company for $6.05

FDA 138

FDA 138

pharmaphorum

MARCH 10, 2022

It says the price increases were imposed “as though a new version of Acthar came on the market in 2013, when in fact, it did not,” which allowed it to ignore all price increases prior to 2013 in its rebate calculations.

105

105

STAT

MAY 1, 2023

San Francisco-based Carbon said that Elevance — formerly known as Anthem, which operates the Anthem Blue Cross plan in California — had refused to increase its payment rate in the state beyond 2013 levels, which was “no longer tenable as a livable wage.” ” Continue to STAT+ to read the full story…

Insurance 92

Insurance 92

Outsourcing Pharma

JANUARY 12, 2021

A Miami physician has owned up to falsifying research data and patient participation figures for a pediatric asthma trial conducted from 2013 to 2016.

77

77

STAT

JUNE 18, 2024

based company was founded in 2013 and has raised $60 million to date. Perekupka said Freespira hopes to enroll 2,500 people in its treatment this year — twice last year’s sales — and to double its patients again in 2025 and 2026. The Kirkland, Wash.-based

Insurance 101

Insurance 101

PharmExec

JULY 7, 2022

In episode 112, Nima Farzan, CEO of Kinnate, who was one of Pharmaceutical Executive’s Emerging Pharma Leaders in 2013, discusses how he’s successfully navigated his career path, from building a foundation in pharma to growing his expertise in biotech.

52

52

STAT

JANUARY 17, 2024

Central Texas’ Scott and White was absorbed into Baylor in 2013. Wisconsin’s Marshfield Clinic agreed to merge with Duluth-based Essentia Health in October 2022 after a lengthy string of operating losses, though the merger fell apart recently.

Hospitals 136

Hospitals 136

STAT

MAY 15, 2023

Hospitals ran short of essential treatment medications and were unable to source those drugs from manufacturers or from the outsourcing facilities that had been authorized by Congress in 2013 to “fill the gap” in such situations.

Compounding Pharmacies 98

Compounding Pharmacies Compounding Hospitals FDA 98

STAT

MARCH 9, 2023

In the spring of 2013, I had just visited a lab focused on gene and cell therapies at Baylor College of Medicine. Bluebird Bio , which would soon launch a successful IPO , had licensed its technology from the same lab and was about to announce a major collaboration with Celgene and Baylor.

94

94

STAT

OCTOBER 12, 2022

A federal law that went into effect in 2013 requires the FDA to identify ingredients needed to satisfy an unmet “clinical need” and to include those on  a list for use by large compounding pharmacies.

Compounding Pharmacies 96

Compounding Pharmacies Compounding FDA 96

STAT

DECEMBER 13, 2022

When it hit the market in 2013, the drug revolutionized the treatment of these cancers and represented a major step forward from chemotherapy and some other drugs at the time. NEW ORLEANS – One of the best therapies for some types of lymphoma and leukemia has been a drug called ibrutinib, made by AbbVie.

Chemotherapy 96

Chemotherapy 96

STAT

JANUARY 8, 2024

The two men worked together from 2013 until 2022, when Jonas left to start a biotech incubator with funding from investment giant CBC Group. The VC firm has hired Jeff Jonas, Sage’s former chief executive, and Al Robichaud, Sage’s former chief scientific officer, as partners, the team told STAT exclusively.

Labelling 110

Labelling FDA 110